VALIDATION OF SICKNESS IMPACT PROFILE AND PSORIASIS DISABILITY INDEX IN PSORIASIS

被引：238

作者：

FINLAY, AY ^{[1
]}

KHAN, GK ^{[1
]}

LUSCOMBE, DK ^{[1
]}

SALEK, MS ^{[1
]}

机构：

[1] UNIV COLL CARDIFF,MED RES UNIT,CARDIFF CF1 1XL,S GLAM,WALES

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1990年 / 123卷 / 06期

关键词：

D O I：

10.1111/j.1365-2133.1990.tb04192.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

A prospective cross-sectional questionnaire study of 32 patients with psoriasis was carried out in order to validate the use of the Sickness Impact Profile (SIP) in psoriasis and compare its sensitivity with the Psoriasis Disability Index (PDI). Overall PDI scores, but not overall SIP scores, correlated well with PASI scores (P < 0.05). There was good correlation between the PDI and overall SIP scores (P < 0.01). Psychosocial factors are more severely impaired than physical activities in patients with psoriasis. It is now possible to directly compare the disability experienced by psoriatic patients with that experienced by patients suffering from other systemic diseases, using the SIP. The PDI is an appropriate method to give a rapid overall measure of psoriasis disability.

引用

页码：751 / 756

页数：6

共 7 条

[1] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].

BERGNER, M ;

BOBBITT, RA ;

CARTER, WB ;

GILSON, BS .

MEDICAL CARE, 1981, 19 (08) :787-805

[2] PSORIASIS - AN INDEX OF DISABILITY [J].

FINLAY, AY ;

KELLY, SE .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1987, 12 (01) :8-11

[3] SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].

FREDRIKSSON, T ;

PETTERSSON, U .

DERMATOLOGICA, 1978, 157 (04) :238-244

[4] ASSESSMENT OF DISEASE PROGRESS IN PSORIASIS [J].

MARKS, R ;

BARTON, SP ;

SHUTTLEWORTH, D ;

FINLAY, AY .

ARCHIVES OF DERMATOLOGY, 1989, 125 (02) :235-240

[5] HOW MUCH DISABILITY IS CAUSED BY ACNE [J].

MOTLEY, RJ ;

FINLAY, AY .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1989, 14 (03) :194-198

[6]

SALEK MS, 1988, J DRUG THERAPY RES, V13, P186

[7]

SALEK MS, 1988, BR J CLIN PHARM, V26, P628

← 1 →